Prosecution Insights
Last updated: April 19, 2026
Application No. 16/633,701

COMPOUND AND METHOD FOR PRODUCING THE SAME

Non-Final OA §103
Filed
Jan 24, 2020
Examiner
LEE, JIA-HAI
Art Unit
1658
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Pusan National University Industry-University Cooperation Foundation
OA Round
7 (Non-Final)
50%
Grant Probability
Moderate
7-8
OA Rounds
3y 0m
To Grant
97%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allow Rate
215 granted / 432 resolved
-10.2% vs TC avg
Strong +47% interview lift
Without
With
+47.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
65 currently pending
Career history
497
Total Applications
across all art units

Statute-Specific Performance

§101
2.8%
-37.2% vs TC avg
§103
37.7%
-2.3% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
19.4%
-20.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 432 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 9/5/2025 has been entered. Claim Status Claims 1-9, 11-15, and 20 are pending. Claims 10 and 16-19 is cancelled. The elected species of L-glutamate N-carboxyanhydride dated 11/10/2021 is still valid. According to the previous office action dated 10/30/2024, claim 2 is interpreted as a linear homopolymer of L-glutamate in consistent with the species election. Any peptide sequences NOT homopolymer of L-glutamate will be withdrawn in compliance with RCE filing. Thus, claims 4, 6, and 8 are withdrawn as being directed to a non-elected species. Claims 1 and 11-15 are withdrawn as being directed to a non-elected compound invention, the election having been made on 11/10/2021. Claims 2-3, 5, 7, 9, and 20 have been examined. Priority This application is a 371 of PCT/KR2018/008328 filed on 07/24/2018, which claim foreign priority of REPUBLIC OF KOREA10-2017-0093530 filed on 07/24/2017. Claim Objections Claims 5 and 20 objected to because of the following informalities:. Appropriate correction is required. Claims 5 and 20 are improper Markush group because the phrase “… selected from a group consisting of …” in claim 5 (line 2) and in claim 20 (line 3-4) should be “selected from the group consisting of”. Furthermore, the examiner suggest applicant to amend claim 20 as follow. The method of claim 2, wherein in Chemical Formula 2, a hydrogen atom of each of the alkyl group, the cycloalkyl group, the aryl group and the cycloalkenyl group and optionally substituted the group consisting of an ether group, a carbonyl group, an alkenyl group, an allyl group, a halogen atom, a hydroxy group, a phenyl group, and a cyano group. Modified Rejection Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 2-3, 5, 7, 9 and 20 are rejected under 35 U.S.C. 103 as being unpatentable over Guo et al. (J. Am. Chem. Soc. 2012, 134, 9163−9171, previously cited 1/10/2022) in view of Fevre et al. (Polym. Chem. 2013; (4):1995-2003, previously cited 1/10/2022), Cheng et al. (Top Curr Chem. 2012:310:1-26) and evidenced by (i) De Greef et al. (Chem. Rev. 2009; 109: 5687–5754) and (ii) Deming et al. (Chem. Rev. 2016, 116, 786−808). Claim 2 is drawn to a method for producing a linear polypeptide comprising: preparing a mixture of an α-amino acid N-carboxyanhydride and an organic solvent in an oxygen-removed and dried reaction vessel; PNG media_image1.png 146 158 media_image1.png Greyscale adding an a hexylamine compound to the reaction vessel; adding an anhydrous catalyst represented by a following Chemical Formula 2 to the reaction vessel; reacting the α-amino acid N-carboxyanhydride with the anhydrous catalyst in an anhydrous reaction to produce a linear polypeptide; and wherein the linear polypeptide produced using the method has a polydispersity index (PDI) of 1.5 or lower. PNG media_image2.png 148 166 media_image2.png Greyscale PNG media_image3.png 398 704 media_image3.png Greyscale Guo et al. teach a method for producing a compound of polymerizing α-amino acid N-carboxyanhydride using N-heterocyclic carbene of NHC 1 or a functional equivalent analogue as a catalyst for ring open polymerization of amino acids (reading on α-amino acid N-carboxyanhydride) in an anhydrous reaction shown as follows (p9164, scheme 1) to produce linear polymer by end-capping with electrophiles (e.g., acetyl chloride) (p9170, col 2, line 1-3). Guo et al. further show the method has a polydispersity index (PDI) of 1.5 or lower (pS4, Table S1; pS5, Table S2). Guo et al. teach the polymerization reaction is performed under a nitrogen atmosphere before isolation of the polymer (p9165, col 1, last para; S2, Experimental details, para 1), but do not teach the use of N-heterocyclic carbene with a pharmaceutical sat of HCO3-. Similarly, Fevre et al. teach NHCs are relative instable when exposed to air makes them difficult to handle. As a consequence, NHCs must often be stored and manipulated under dry and inert conditions. Fevre et al. teach a general strategy to circumvent this limitation is to convert the NHC into a masked form, the in situ generation of the free NHC being generally achieved by PNG media_image4.png 196 168 media_image4.png Greyscale thermal activation (p1995, col 2, para 2). Fevre et al. teach [NHC(H)][HCO3-] pre-catalysts (p1998, Fig 1) are air-stable and easily accessible via a one-step undemanding process (p2002, col 1, Conclusion). Fevre et al. further teach all experiments were performed under an inert atmosphere using standard Schlenk techniques. Dry, oxygen-free solvents and reagents were employed (p1996, col 1, Materials). Because Fevre et al. teach beneficial use of a stable and easily accessible [NHC(H)][HCO3-] pre-catalyst to substitute Guo’s air-sensitive NHC catalysts for ring-opening polymerisations, one of ordinary skill in the art would have found it obvious to prepare the reactants of mixed α-amino acid N-carboxyanhydride and an organic solvent in an oxygen-removed and dried reaction vessel for conducting the polymerization reaction according to Guo’s scheme 1 shown above. Guo et al. in view of Fevre et al. did not specify adding a hexylamine compound to the reaction of Ring-Opening Polymerization of α-Amino Acid N-Carboxyanhydrides. Cheng et al. teach Synthesis of Polypeptides by Ring-Opening Polymerization of α-Amino Acid N-Carboxyanhydrides (Title). Cheng et al. teach beneficially adding n-hexylamine initiator to polymerization solvents for ring-open polymerization of γ-benzyl-L-glutamate NCA (p3, 2nd last para) shown as follows (p5, scheme 2). PNG media_image5.png 390 1018 media_image5.png Greyscale De Greef et al. is cited to show common knowledge of adding a small amount of initiator lowering the value of polydispersity index (p5694, Col 2, para 1) by preventing monomers from reacting with each other (p5716, col 2, para 1) known in the art. Consistently, Deming is further cited to show polymerization of side chain modified L-glutamate NCA in the presence of an initiator to generate a homopolymer with polydispersity index of 1.05 (p792, col 2, para 2) known in the art. With respect to the limitation (i), Guo et al. teach the polymerization in a polar solvent of DMSO or DMF without water for synthesis a polymer of low molecular weight (p9170, col 2, line 8). Guo et al. show polymerization of an α-amino acid N-carboxyanhydride in an organic solvent with an N-Heterocyclic carbene (NHC) as a catalyst (p9164, scheme 1). Guo et al. teach the polymerization reaction is performed under a nitrogen atmosphere before isolation of the polymer (p9165, col 1, last para; S2, Experimental details, para 1). Similarly, Fevre et al. teach all experiments were performed under an inert atmosphere using standard Schlenk techniques. Dry, oxygen-free solvents and reagents were employed (p1996, col 1, Materials). With respect to the limitation (ii), Cheng et al. teach adding n-hexylamine initiator to polymerization solvents for polymerization of γ-benzyl-L-glutamate NCA (p3, 2nd last para) shown in scheme 2 (p5). De Greef et al. teach the addition of a small amount of initiator lowering the value of polydispersity index to a value of 1.5 (p5694, Col 2, para 1) by preventing monomers from reacting with each other (p5716, col 2, para 1). Consistently, Deming et al. teach polymerization of side chain modified L-glutamate NCA in the presence of an initiator to generate a homopolymer with polydispersity index of 1.05 (p792, col 2, para 2). With respect to the limitation (iii), Guo et al. show addition of N-heterocyclic carbene of NHC 1 or a functional equivalent analogue as a catalyst for ring open polymerization of amino PNG media_image4.png 196 168 media_image4.png Greyscale acids to produce a linear peptide (p9164, scheme 1). Fevre et al. teach beneficial use of air-stable and easily accessible [NHC(H)][HCO3-] pre-catalysts (p1998, Fig 1) converted to active catalyst by the thermal activation (p1995, col 2, para 2; p2002, col 1, Conclusion). With respect to the limitation (iv), Guo et al. in view of Fevre et al. teach addition of [NHC(H)][HCO3-] pre-catalysts for ring open polymerization of amino acids to produce a linear peptide (p9164, scheme 1) in organic solvent ,such as DMF, under a nitrogen atmosphere and anhydrous condition (See Guo et al. p9164, scheme 1; p9170, col 2, line 8). With respect to the limitation (v), Guo et al. further show the method has a polydispersity index (PDI) of 1.5 or lower (pS4, Table S1; pS5, Table S2). De Greef et al. teach the addition of a small amount of initiator lowering the value of polydispersity index to a value of 1.5 (p5694, Col 2, para 1) by preventing monomers from reacting with each other (p5716, col 2, para 1). Consistently, Deming et al. teach polymerization of side chain modified L-glutamate NCA in the presence of an initiator to generate a homopolymer with polydispersity index of 1.05 (p792, col 2, para 2). One of ordinary skill in the art before the effective filing date of this invention would have found it obvious to modify Guo’s method for producing a compound of polymerizing α-amino acid N-carboxyanhydride with Fevre’s pre-catalysts for ring open polymerization of amino acids to produce a linear peptide because (a) Guo et al. teach polymerizing α-amino acid N-carboxyanhydride using N-heterocyclic carbene and (b) Fevre et al. teach beneficial use of a stable and easily accessible [NHC(H)][HCO3-] pre-catalyst to substitute Guo’s air-sensitive NHC catalysts for ring-opening polymerisations (p2002, col 1, Conclusion). The modification would have reasonable expectation of success because Fevre’s [NHC(H)][HCO3-] pre-catalyst can become the active catalyst by thermal activation (p1995, col 2, para 2). One of ordinary skill in the art before the effective filing date of this invention would have found it obvious to combine (i) Guo et al. in view of Fevre et al. with (ii) Cheng et al. because (a) Guo et al. in view of Fevre et al. teach ring-opening polymerization of α-amino acid N-carboxyanhydrides and (b) Cheng et al. teach beneficially adding n-hexylamine initiator to polymerization solvents for polymerization of γ-benzyl-L-glutamate NCA (p3, 2nd last para) shown by Scheme 2 (p5). The combination would have reasonable expectation of success because all references teach ring-opening polymerization of α-amino acid N-carboxyanhydrides. De Greef et al. is cited to show common knowledge of adding a small amount of initiator lowering the value of polydispersity index (p5694, Col 2, para 1) by preventing monomers from reacting with each other (p5716, col 2, para 1) known in the art. Consistently, Deming is further cited to show polymerization of side chain modified L-glutamate NCA in the presence of an initiator to generate a homopolymer with polydispersity index of 1.05 (p792, col 2, para 2) known in the art. PNG media_image6.png 120 142 media_image6.png Greyscale With respect to claims 3 and 20, Fevre et al. show the air-stable and easily accessible [NHC(H)][HCO3-] pre-catalyst of compound 4a shown as follows, reading on the limitation and elected species of claim 3 (p1998, Fig 1) and a hydrogen atom of each of the alkyl group of claim 20. With respect to claim 5, Guo et al. teach the synthesized product is poly(N-butyl glycine) (p9164, col 2, Results and Discussion, line 3), reading on L-glycine N-carboxyanhydride for polymerization of a liner peptide. Cheng et al. teach adding n-hexylamine initiator to polymerization solvents for polymerization of γ-benzyl-L-glutamate NCA (p3, 2nd last para) shown in scheme 2 (p5), reading on the elected species of L- glutamate N-carboxyanhydride. PNG media_image7.png 325 378 media_image7.png Greyscale With respect to claim 7, Guo et al. teach the polymerization reaction is in an inert N2 atmosphere (pS12, Table S6). With respect to claim 9, Guo et al. teach the reaction time of polymerization is within 100 minutes shown as follows (p9165, Fig 1). Applicant’s Argument None of the cited references teach adding hexylamine compound to the reaction (Remarks, p12. Obviousness Rejection to p15) Response to Arguments Applicant's arguments filed 9/5/2025 have been fully considered but they are not persuasive because the arguments do not apply to the modified rejection based on Guo et al. (J. Am. Chem. Soc. 2012, 134, 9163−9171, previously cited 1/10/2022) in view of Fevre et al. (Polym. Chem. 2013; (4):1995-2003), Cheng et al. (Top Curr Chem. 2012:310:1-26) and evidenced by (i) De Greef et al. (Chem. Rev. 2009; 109: 5687–5754) and (ii) Deming et al. (Chem. Rev. 2016, 116, 786−808). In particular, Cheng et al. teach beneficially adding n-hexylamine initiator to polymerization solvents for polymerization of γ-benzyl-L-glutamate NCA (p3, 2nd last para) shown in scheme 2 (p5). De Greef et al. is cited to show common knowledge of adding a small amount of initiator lowering the value of polydispersity index (p5694, Col 2, para 1) by preventing monomers from reacting with each other (p5716, col 2, para 1) known in the art. Consistently, Deming is further cited to show polymerization of side chain modified L-glutamate NCA in the presence of an initiator to generate a homopolymer with polydispersity index of 1.05 (p792, col 2, para 2) known in the art. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JIA-HAI LEE whose telephone number is (571)270-1691. The examiner can normally be reached Mon-Fri from 9:00 AM to 6:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Melissa Fisher can be reached at 571-270-7430. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /J.L/Examiner, Art Unit 1658 03-January-2026 /LI N KOMATSU/Primary Examiner, Art Unit 1658
Read full office action

Prosecution Timeline

Jan 24, 2020
Application Filed
Jan 05, 2022
Non-Final Rejection — §103
Apr 08, 2022
Response Filed
Aug 04, 2022
Non-Final Rejection — §103
Jan 09, 2023
Response Filed
Apr 06, 2023
Final Rejection — §103
Jul 10, 2023
Request for Continued Examination
Jul 17, 2023
Response after Non-Final Action
Feb 01, 2024
Final Rejection — §103
Jun 07, 2024
Request for Continued Examination
Jun 11, 2024
Response after Non-Final Action
Oct 19, 2024
Non-Final Rejection — §103
Jan 29, 2025
Response Filed
Apr 23, 2025
Final Rejection — §103
Sep 05, 2025
Request for Continued Examination
Sep 09, 2025
Response after Non-Final Action
Jan 03, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12569543
Semaglutide in Cardiovascular Conditions
2y 5m to grant Granted Mar 10, 2026
Patent 12453778
Incremental Dose Finding in Controlled-Release PTH Compounds
2y 5m to grant Granted Oct 28, 2025
Patent 12377172
METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER
2y 5m to grant Granted Aug 05, 2025
Patent 12372529
USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
2y 5m to grant Granted Jul 29, 2025
Patent 12303547
COMPOUND, USE, PHARMACEUTICAL COMPOSITION, METHOD OF DIAGNOSIS, METHOD OF TREATMENT, AND METHOD OF TRANSPORTATION AND/OR INTERNALIZATION OF A COMPOUND INTO EUKARYOTIC CELLS
2y 5m to grant Granted May 20, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
50%
Grant Probability
97%
With Interview (+47.2%)
3y 0m
Median Time to Grant
High
PTA Risk
Based on 432 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month